Is chemical sunscreen dangerous?

Demonstrated dangerous, no; incompletely characterised at the margins, yes. Several chemical filters absorb into blood above the threshold at which the FDA requires further safety data — a data obligation, not a harm finding, as the agency stated while telling the public to keep using sunscreen. Decades of use have produced no demonstrated clinical harm at real-world exposures, with oxybenzone carrying the most legitimate residual questions and already fading from formulations. Anyone who prefers certainty can switch to zinc oxide or titanium dioxide, which stay on the skin surface and hold the FDA's full safe-and-effective classification. What the evidence cannot support is the leap from 'absorbed' to 'toxic' to 'skip sunscreen' — the last step of which trades an unquantified hypothetical against a proven carcinogen.

Does sunscreen cause vitamin D deficiency?

In real-world use, no measurable effect: people apply a fraction of the tested quantity, miss skin, and reapply rarely, so meaningful vitamin D synthesis continues — field studies of habitual users show vitamin D status equal or nearly equal to non-users. Populations genuinely at deficiency risk (deeply pigmented skin at high latitudes, full-body clothing, institutionalised elderly) are deficient for reasons sunscreen does not explain, and the corrective is supplementation — cheap, titratable and carcinogen-free — rather than intentional UV. Framing it as sunshine-versus-rickets is a false dilemma that a vitamin D tablet dissolves.

What about the benzene found in sunscreens?

Benzene was a manufacturing contaminant, not an ingredient — detected in 2021 in a minority of batches, concentrated in certain aerosol products, traced to production components, and followed by recalls. The same testing initiative found benzene in dry shampoos, deodorants and hand sanitisers; the finding indicts quality control in consumer-product manufacturing generally. Reasonable responses: prefer lotions over aerosols if concerned, use established brands, check recall lists. Unreasonable response: unprotected exposure to solar UV — a Group 1 carcinogen at doses no contaminated batch approaches — to avoid parts-per-million contamination that regulators removed from sale.

Should I use mineral sunscreen for coral reefs?

If swimming on reefs, mineral sunscreen (non-nano formulations if you want maximal caution) is a defensible courtesy and required by law in Hawaii and several island jurisdictions — but hold the proportions honestly. Laboratory coral toxicity of oxybenzone occurs at concentrations rarely approached in open reef water, and reef scientists attribute bleaching overwhelmingly to warming seas, acidification and land runoff. 'Reef-safe' labels are unregulated marketing. Sunscreen choice is a minor personal courtesy to reefs; anyone motivated by coral has vastly larger levers in climate and coastal policy, and skipping sun protection helps no reef while harming one swimmer.

Do higher SPF numbers matter?

Less than the marketing implies, and less than technique. SPF 30 blocks about 97% of UVB and SPF 50 about 98% under test conditions — but consumers apply a quarter to a half of the test quantity, which collapses realised protection non-linearly, so the higher label functions mainly as a buffer for under-application. The variables that actually move outcomes: broad-spectrum (UVA) certification, enough product (roughly a shot-glass for an adult body, a teaspoon for face and neck), reapplication every two hours and after water, and water resistance matched to activity. A generously applied, regularly renewed SPF 30 outperforms a decorative film of SPF 100 every time.

Is some sun exposure healthy?

The honest answer has layers. Vitamin D synthesis needs only brief incidental exposure well short of burning, and can be replaced by supplementation. An emerging research line suggests possible UV benefits beyond vitamin D — nitric-oxide-mediated blood pressure effects among them — interesting, unproven as a basis for advice, and championed most loudly by people skipping past melanoma statistics. Consensus guidance already accommodates the reasonable core: sun protection matters most between high-UV hours and burns are never acceptable, while incidental low-UV exposure is not the enemy. What no evidence supports is tanning — a visible marker of DNA damage — or the influencer claim that sunscreen, rather than the Group 1 carcinogen it blocks, causes skin cancer.

Home › Topics › Sunscreen Safety

Sunscreen Safety

GMJ News knowledge hub · last reviewed September 2026 · Georgian Medical Journal

Summary Statistics Glossary GMJ news FAQ Documents Organizations Research

Sunscreen sits in a peculiar position: ultraviolet radiation is a proven Group 1 human carcinogen and randomised trial evidence shows regular sunscreen use roughly halves invasive melanoma incidence, yet a growing online movement holds that sunscreen itself is the hazard. The kernel of legitimate science inside the scare is real but narrow: FDA studies confirmed that several chemical UV filters are absorbed into blood above the agency’s testing threshold — which triggered a demand for more safety data, not a finding of harm — and benzene contamination episodes in 2021 were a manufacturing failure, not a property of sunscreen. Weighed against a preventable cancer with over 300,000 global cases a year, the evidence remains lopsidedly in favour of sun protection, with mineral filters available for anyone who wants to bypass the absorption question entirely (WHO ultraviolet radiation fact sheet).

Key messages

SETTLED: UV causes skin cancer and sunscreen prevents it

Ultraviolet radiation is a Group 1 human carcinogen responsible for the large majority of skin cancers, and sunscreen has randomised trial evidence — rare in cancer prevention. The Australian Nambour trial randomised adults to daily versus discretionary sunscreen for four and a half years: squamous cell carcinoma fell during the trial, and at ten-year follow-up invasive melanoma was roughly halved in the daily-use group. Population programmes built on sun protection (Australia's SunSmart) accompanied the first declines in melanoma incidence in younger cohorts. The anti-sunscreen position must argue against a randomised trial and a Group 1 carcinogen simultaneously; it does not attempt to.

REAL BUT MISREAD: the FDA absorption studies

The scientific kernel of the scare is genuine: FDA studies published in 2019-2020 showed that several chemical filters (avobenzone, oxybenzone, octocrylene and others) reach plasma concentrations above 0.5 ng/mL — the threshold beyond which FDA requires additional toxicological data — after maximal application. What the finding means is exactly what the FDA said it means: absorption above the data-waiver threshold obliges manufacturers to supply safety studies, and does not indicate the ingredients are unsafe, and people should keep using sunscreen. 'Absorbed' became 'toxic' only in the retelling. Mineral filters (zinc oxide, titanium dioxide) are classified GRASE and bypass the question entirely for anyone it worries.

GENUINELY OPEN: oxybenzone endocrine questions and the regulatory gap

Oxybenzone shows weak hormonal activity in laboratory assays and is the filter with the least favourable profile; human studies show no demonstrated clinical effect at real-world exposures, but the margin between laboratory activity and human exposure is narrower than for other filters, and its use is declining, with Hawaii and other jurisdictions restricting it on coral-reef grounds. The structural problem behind the whole debate is regulatory: the US classifies sunscreens as drugs and has approved no new UV filter since 1999, leaving American formulations a generation behind the newer European and Asian filters that offer better UVA protection with lower absorption — a gap that legislation (SAFE Sunscreen Standards Act, 2025) has moved to close.

MANUFACTURING, NOT CHEMISTRY: the benzene episodes

The 2021 discovery of benzene — a genuine Group 1 carcinogen — in a minority of sunscreen batches, followed by recalls, is routinely cited as evidence against sunscreen itself. Benzene is not a sunscreen ingredient; it was a contaminant traced to manufacturing components, found also in dry shampoos, deodorants and hand sanitisers tested by the same laboratory. The correct target of that finding is pharmaceutical quality control, and the appropriate consumer response is using products from manufacturers with clean testing — not sun exposure without protection, which trades a contamination risk measured in parts per million against a proven carcinogen delivered by the megajoule.

MOSTLY MISDIRECTED: the vitamin D objection

The claim that sunscreen causes vitamin D deficiency fails empirically: real-world application (people apply a quarter to a half of test quantities, miss areas and reapply rarely) still permits vitamin D synthesis, and field studies of habitual sunscreen users show little to no difference in vitamin D status. For the minority genuinely at risk of deficiency — dark skin at high latitude, full-coverage clothing, the housebound and elderly — the evidence-based answer is inexpensive supplementation, not deliberate accumulation of a Group 1 carcinogen. The tan-versus-D framing offers a false trade that supplementation dissolves for a few cents a day.

WEAK IN THE FIELD: the coral reef case

Reef protection is the one anti-sunscreen argument with regulatory wins, and its evidence is thinner than its legislation. Laboratory studies show oxybenzone toxicity to coral larvae at concentrations far above almost all measured reef water levels; field-scale attribution is negligible next to ocean warming, acidification and runoff — the actual drivers of bleaching. Reef-jurisdiction bans are defensible precaution with real symbolic value and little measured conservation effect; 'reef-safe' on a label, meanwhile, is an unregulated marketing term. Choosing mineral sunscreen for reef swimming is reasonable; believing sunscreen choice is coral conservation policy is not.

Key statistics

~50%

reduction in invasive melanoma at 10-year follow-up of the randomised Nambour daily-sunscreen trial

Green et al., JCO 2011

Group 1

IARC classification of solar UV radiation — a proven human carcinogen

IARC

330,000+

new melanoma cases globally per year, with incidence rising in fair-skinned populations

WHO/IARC Globocan

0.5 ng/mL

FDA plasma threshold above which UV filters require additional safety data — exceeded by several chemical filters in 2019-2020 studies

FDA/JAMA

1999

the last year the US FDA approved a new UV filter — the regulatory lag behind European and Asian formulations

FDA

25-50%

of the tested application quantity that consumers typically apply in real life — why real-world SPF underperforms the label

Dermatology literature

Sunscreen — where the disagreement actually lies

Source: Bars show strength of supporting evidence. High values indicate well-supported propositions; low values indicate claims tested and not supported.

Glossary of key terms

The Nambour trial
EvidenceConducted in Queensland — the world's melanoma capital — the Nambour Skin Cancer Prevention Trial randomised over 1,600 adults to daily sunscreen application versus discretionary use from 1992 to 1996. Squamous cell carcinoma fell significantly during the trial period; basal cell carcinoma did not change significantly; and the landmark result arrived at ten-year follow-up, when invasive melanomas were reduced by roughly three-quarters and all melanomas by about half in the daily-use group. It remains the only randomised melanoma-prevention evidence for sunscreen, with the usual caveats of a single trial in one high-UV population — and it is the piece of evidence the anti-sunscreen movement most consistently declines to engage.

Chemical versus mineral filters
PharmacologyChemical (organic) filters — avobenzone, oxybenzone, octocrylene, homosalate and newer molecules — absorb UV and dissipate it as heat; they formulate elegantly but several absorb through skin into plasma. Mineral (inorganic) filters — zinc oxide and titanium dioxide — reflect, scatter and absorb UV while remaining essentially on the skin surface; the FDA classifies both as generally recognised as safe and effective, at the cost of heavier textures and white cast (reduced in modern micronised forms, whose nanoparticles do not penetrate intact skin per current evidence). The practical translation: anyone troubled by the absorption findings has a fully validated alternative on the same shelf, which makes abandoning sun protection the one choice the controversy cannot justify.

The 2019-2020 FDA absorption studies
Regulatory scienceThe FDA's own investigators applied four commercial sunscreens at maximal-use conditions — repeated application over 75% of body surface — and measured plasma filter concentrations, finding all tested chemical filters above the 0.5 ng/mL threshold that triggers requirements for additional nonclinical safety data, with some persisting days after application. The studies were published in JAMA with an editorial and an explicit agency statement carrying two messages the subsequent discourse severed: the results do not mean the ingredients are unsafe, and consumers should continue using sunscreen while data are generated. The episode became a case study in how a data-gap finding is converted into a harm finding by removing the regulatory context.

GRASE and the frozen US filter list
PolicyUS sunscreens are regulated as over-the-counter drugs under a monograph system that has not admitted a new UV filter since 1999; the FDA's 2019 proposed order classified only zinc oxide and titanium dioxide as GRASE (generally recognised as safe and effective), placed twelve chemical filters in the additional-data category, and stalled. Europe, Japan and Korea meanwhile approved a generation of filters — bemotrizinol, bisoctrizole and others — offering photostable broad-spectrum UVA protection with minimal systemic absorption. The result is the debate's central irony: the country with the loudest sunscreen-safety controversy is the one whose regulatory process locks consumers out of the filters that would answer it. Legislation to modernise the pathway advanced in 2025.

UVA, UVB and what SPF does not measure
PhotobiologySPF measures protection against erythema — sunburn — which is driven predominantly by UVB. UVA, penetrating deeper and constituting most terrestrial UV, drives photoageing and contributes to melanoma through indirect DNA damage, and is only captured by separate broad-spectrum, PA or UVA-circle standards. This gap explains a real historical criticism the scare distorts: early sunscreens prevented the burn (the warning signal) while allowing UVA accumulation, potentially enabling longer exposure — a formulation problem largely solved by modern broad-spectrum standards, not an indictment of the concept. It is also why 'high SPF' bidding wars matter less than broad-spectrum coverage, adequate quantity and reapplication.

Sun protection as a system
Public healthSunscreen was always designed as the last layer, not the strategy — the hierarchy runs shade and timing (avoiding peak UV, using the UV index), clothing, hats and sunglasses, then sunscreen on what remains exposed. Australia's decades-long SunSmart programme, built on that full hierarchy, accompanies the first generational declines in melanoma incidence and is the closest thing to population-level proof of concept. The framing also answers the 'humans evolved in the sun' argument on its own terms: humans evolved avoiding midday sun behaviourally, under far more melanin than the fair-skinned populations now colonising high-UV latitudes, and without a doubled lifespan in which slow carcinogenesis can mature.